Updated August 2026: this article was revised to add the confidence intervals behind the headline effect sizes, a fuller drug-interaction and liver-safety section, and a new section on what the evidence does not yet show.
When stress becomes a constant companion, many women look for options that work alongside sleep, movement, and therapy rather than replacing them. Ashwagandha (Withania somnifera), an Ayurvedic herb also called Indian winter cherry, is one of the most heavily studied adaptogens in modern clinical research -- and one of the most heavily oversold.
This article separates the two. Below is what the pooled clinical data actually supports, where the numbers are shakier than the headlines suggest, and the safety details that matter if you take any prescription medication.
Evidence at a Glance
- Serum cortisol reduction -- the most consistent finding. Multiple 2025 meta-analyses agree.
- Anxiety and stress scale scores -- large pooled effect, but with a wide confidence interval and substantial variation between trials.
- Perceived stress -- inconsistent. One 2025 meta-analysis found no significant effect at all.
- Sleep quality -- secondary and less robust than the stress and anxiety outcomes.
- Evidence quality overall -- mostly small trials of 50 to 80 participants, most running 8 to 12 weeks, many funded by supplement manufacturers.
The Cortisol Connection: The Strongest Signal in the Data
Ashwagandha's most reproducible effect is on cortisol, the hormone your adrenal glands release under sustained stress.
A 2025 systematic review and meta-analysis published in BJPsych Open pooled nine studies with 558 participants and found that ashwagandha supplementation significantly reduced cortisol levels, Perceived Stress Scale scores, and Hamilton Anxiety Rating Scale scores compared with placebo.
A separate 2025 meta-analysis put a number on the hormone change: a reduction in serum cortisol of 1.16 micrograms/dL (95% CI: -1.64 to -0.69, P below 0.001). That same analysis, however, found no significant effect on perceived stress (SMD -0.355, 95% CI: -1.188 to 0.47, P = 0.40).
Why the Disconnect Matters
Two credible 2025 analyses reached different conclusions about subjective stress while agreeing on cortisol. That is not a contradiction to explain away -- it is the honest state of the evidence, and it carries a practical implication.
Cortisol lowering alone does not appear to explain how ashwagandha makes people feel. Perceived stress is shaped by sleep, workload, relationships, and coping resources that no capsule reaches. If you are evaluating an adaptogen, the realistic frame is a modest biological adjustment to your stress response, layered onto the behavioural work that does most of the lifting.
Anxiety Scores: Large Effect, Wide Interval
A 2024 systematic review and meta-analysis found that ashwagandha significantly reduced anxiety scores with a large pooled effect size (SMD -1.55, 95% CI: -2.37 to -0.74, P = 0.005).
Two things are true about that number at once. The point estimate is large -- larger than most nutraceutical interventions achieve. And the interval is wide, spanning effects from meaningful to very large, which reflects genuine variation between trials in extract type, dose, population, and outcome scale.
One frequently misquoted detail: dose-response modelling in that analysis indicated favourable effects on anxiety scores at doses up to 12,000 mg per day. This is a statistical artifact of the modelling range, not a recommendation. No safety dataset supports daily intakes anywhere near that figure, and the positive trials overwhelmingly used 300 to 600 mg daily of a standardized extract. Do not read the modelling ceiling as a dosing target.
The Trials Behind the Pooled Numbers
- Chandrasekhar et al. (2012) -- 64 participants, 300 mg KSM-66 twice daily for 60 days. Perceived Stress Scale scores fell 44 percent versus 5.5 percent on placebo; serum cortisol fell 27.9 percent versus 7.9 percent.
- Lopresti et al. (2019) -- 60 participants, 240 mg daily for 60 days. Significant reductions in morning cortisol and in the stress, anxiety, and depression subscales of the DASS-21.
- Salve et al. (2019) -- 60 participants, 125 mg to 600 mg daily for 8 weeks. Dose-dependent improvements in Perceived Stress Scale scores and serum cortisol across that range.
Note the sample sizes. These are the landmark trials, and none of them enrolled more than 64 people.
How Ashwagandha Works: Several Partial Explanations
No single mechanism accounts for the observed effects. Four are proposed, at differing levels of evidence.
HPA Axis Modulation
The hypothalamic-pituitary-adrenal axis is your central stress-response circuit. Chronic stress can leave it persistently activated. Withanolides -- ashwagandha's characteristic compounds -- appear to modulate cortisol synthesis by influencing adrenal cortex function, reducing excessive output during stress without suppressing the basal cortisol you need for normal function. That bidirectional behaviour is what distinguishes an adaptogen from a simple hormone blocker.
GABAergic Activity (Preclinical)
Withaferin A and related withanolides have shown GABA-mimetic activity in laboratory work, binding GABA-A receptors and enhancing inhibitory neurotransmission. This is receptor-level and animal-model evidence, not human imaging or CSF data -- worth stating plainly, because it is routinely reported as though it were a clinical finding. It is nonetheless the most plausible explanation for why anxiety scores move further than cortisol change alone would predict, and it is the reason the sedative interactions further down this page are real rather than theoretical.
Serotonergic Modulation
Ashwagandha has been shown to modulate serotonin receptor activity, particularly the 5-HT1A and 5-HT2 subtypes that are established targets for anti-anxiety and antidepressant compounds. This pathway likely complements the GABAergic one.
Inflammatory and Neuroprotective Signalling
Sustained psychological stress raises pro-inflammatory cytokines including IL-6, TNF-alpha, and CRP. In mechanistic studies, ashwagandha suppresses NF-kB-mediated inflammatory signalling, and withanolides show neuroprotective activity including enhanced BDNF expression and protection against oxidative neuronal damage. These findings are mechanistic and preclinical. They describe a plausible contribution to stress resilience; they are not clinical outcomes in humans.
Sleep: A Secondary Outcome
Several trials have reported improvements in sleep onset latency, total sleep time, and Pittsburgh Sleep Quality Index scores. The NIH Office of Dietary Supplements characterises the sleep evidence as limited and less robust than the stress and anxiety evidence.
Given how tightly poor sleep and chronic stress reinforce each other, sleep improvement may be part of how the herb produces its perceived benefit -- but it should be regarded as a possible secondary effect, not a reason to choose ashwagandha over addressing sleep directly.
Dosage, Standardization, and Reading a Label
Clinical consistency comes from standardized extracts, not generic root powder:
- KSM-66 -- 300 to 600 mg daily, standardized to a minimum 5 percent withanolides by HPLC. A full-spectrum root extract, and the most extensively studied commercial preparation.
- Sensoril -- 125 to 250 mg daily, standardized to a minimum 10 percent withanolides. A root-and-leaf extract, so it reaches a higher withanolide concentration per milligram.
- Generic standardized root extract -- 300 to 600 mg daily at 1.5 to 5 percent withanolides.
Most positive trials split the dose morning and evening with meals, though single daily dosing has also produced results. For sleep support specifically, 300 to 600 mg taken 1 to 2 hours before bed is the pattern used in the literature.
Check the label for piperine. Many botanical formulations add piperine (often as BioPerine) to raise absorption. Piperine inhibits CYP3A4, CYP2C9, CYP1A2, and P-glycoprotein -- the systems that clear roughly half of all pharmaceuticals. A piperine-containing product carries meaningfully higher drug-interaction risk than the same botanical without it. If you take prescription medication, a piperine-free formulation is the more conservative choice.
Safety: Well Tolerated, With Real Boundaries
Adverse effects in clinical trials are generally comparable to placebo. That is the headline, and it is genuine. The exceptions below are specific rather than universal, and they matter.
Common and Transient
Mild gastrointestinal symptoms -- nausea, loose stools -- in a small share of users, usually in the first days and usually self-resolving.
Thyroid
Multiple clinical studies show ashwagandha raises serum T3 and T4 and lowers TSH. Two distinct risks follow. If you take levothyroxine for hypothyroidism, ashwagandha can push you toward thyroid hormone excess; cases of ashwagandha-associated thyrotoxicosis in patients on stable levothyroxine doses are documented in the medical literature. If you have hyperthyroidism or Graves' disease, it may work directly against methimazole or propylthiouracil. Either way, this is an endocrinologist conversation before the first capsule, with TSH and free T4 checked at baseline and again at 4 to 8 weeks.
Liver
Rare case reports of liver injury associated with ashwagandha have been published, and the NIH Office of Dietary Supplements flags this as a potential concern. Causality has not been firmly established and the reports are uncommon relative to how widely the herb is used. Still, it belongs in an honest safety section: stop and seek medical assessment if you develop unexplained fatigue with dark urine, yellowing of the skin or eyes, or right-upper-abdominal pain.
Sedatives and Other CNS Depressants
Because ashwagandha acts as a positive allosteric modulator of GABA-A receptors, the interaction with central nervous system depressants is pharmacodynamic and additive rather than hypothetical. This includes benzodiazepines (alprazolam, lorazepam, diazepam, clonazepam), non-benzodiazepine sleep aids (zolpidem, eszopiclone, suvorexant), opioid analgesics, gabapentinoids (gabapentin, pregabalin), and alcohol. The combination can produce sedation beyond what either agent causes alone, with particular concern for impaired driving and for falls in older adults. If you take any of these, your prescriber needs to know before you start.
Immunosuppressants
Ashwagandha enhances natural killer cell activity, T-cell proliferation, and macrophage activation, which directly opposes calcineurin inhibitors (tacrolimus, cyclosporine), biologics, and corticosteroids used for immune suppression. It is contraindicated for organ transplant recipients and for people on immunosuppressive therapy for autoimmune conditions.
Blood Pressure and Blood Glucose
Ashwagandha has mild blood-pressure-lowering and glucose-lowering effects. Combined with antihypertensives, that raises the risk of additive hypotension -- dizziness or lightheadedness on standing. Combined with insulin or sulfonylureas, it raises the risk of additive hypoglycaemia. Neither is a reason to avoid the herb outright, but both are reasons to monitor and to tell your prescriber.
Pregnancy
Not recommended during pregnancy, based on potential abortifacient effects observed in animal studies.
What the Evidence Does Not Show
An honest account of ashwagandha has to include the gaps, because they shape how much weight the positive findings can carry.
- The trials are small. Most individual RCTs enroll 50 to 80 participants, which limits statistical power and inflates the chance that a positive result reflects noise.
- The trials are short. Typical duration is 8 to 12 weeks. Efficacy and safety data beyond three months are sparse, so daily indefinite use is not something the evidence base has actually tested.
- The extracts are not interchangeable. KSM-66, Sensoril, and generic preparations differ in plant part and withanolide profile. Pooling them in a meta-analysis is a compromise, and it is part of why the confidence intervals are wide.
- Funding bias is a live concern. Many trials are sponsored by supplement manufacturers, which is associated with more favourable reporting across the nutraceutical literature generally.
- The mechanism is incomplete. The cortisol-versus-perceived-stress dissociation means the field does not yet have a settled account of how the herb produces its subjective effects.
None of this makes ashwagandha a bad choice. It makes it a moderately supported one, which is a different and more useful thing to know.
Where Ashwagandha Fits Alongside Other Approaches
Because ashwagandha works largely top-down through the HPA axis, it leaves a second stress pathway untouched: the gut-brain axis, where chronic cortisol elevation reshapes the microbiome and the microbiome signals back to the brain along the vagus nerve. Research on psychobiotics -- probiotic strains with demonstrated effects on mood and stress markers -- specifically identifies ashwagandha, L-theanine, and magnesium as complementary anxiolytic mechanisms worth pairing with those strains, precisely because they act through different biology.
If that pairing is what you are evaluating, we cover the mechanics and the honest limits of the combination in Can You Take Ashwagandha and Probiotics Together?. For ingredient-level detail on the extract itself, see our KSM-66 ashwagandha profile; for the wider interaction picture across supplements, see Supplement Safety: Critical Drug Interactions Every Woman Should Know.
Setting Realistic Expectations
Timeline
Anxiety-scale changes in the trial literature start appearing around 2 to 4 weeks; the fuller adaptogenic picture typically takes 4 to 8 weeks of consistent daily use. Nothing in this evidence base supports expecting a same-day effect.
Individual Variation
Baseline stress level, sleep, diet, activity, and overall health all influence response, and a meaningful share of people in these trials did not respond. Trial averages are not a prediction about you.
Complementary, Not Substitutive
Ashwagandha performs best as one component of a stress approach that also includes adequate sleep, regular movement, and real recovery time. It is not a substitute for care if anxiety is interfering with your ability to function -- that warrants a qualified provider, not a capsule.
Key Takeaways
- Cortisol reduction is the best-supported effect, quantified at 1.16 micrograms/dL in a 2025 meta-analysis, and it is reproducible across analyses.
- Anxiety-scale improvement is large but imprecise (SMD -1.55, 95% CI: -2.37 to -0.74), and perceived stress did not move significantly in one credible 2025 analysis.
- 300 to 600 mg daily of a standardized extract for 4 to 8 weeks is the evidence-supported pattern. The 12,000 mg figure circulating online is a modelling artifact, not a dose.
- The safety exceptions are specific: thyroid medication, sedatives and other CNS depressants, immunosuppressants, antihypertensives, glucose-lowering drugs, and pregnancy. Rare liver-injury reports exist and are worth knowing about.
- The evidence base is moderate, not settled -- small, short, heterogeneous, and often industry-funded trials.
Ashwagandha is a reasonable, well-tolerated option for women looking to support their stress response, provided you go in with calibrated expectations and check it against your medication list first. As with any supplement, discuss it with your healthcare provider if you have existing health conditions or take prescription medication.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement regimen.
